Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (27)

2022

  1. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

2020

  1. Intensity normalization methods in brain FDG-PET quantification

    NeuroImage, Vol. 222

2018

  1. Optimization of the reconstruction parameters in [123I]FP-CIT SPECT

    Physics in Medicine and Biology, Vol. 63, Núm. 8

2015

  1. Monte Carlo simulations versus experimental measurements in a small animal PET system. A comparison in the NEMA NU 4-2008 framework

    Physics in Medicine and Biology, Vol. 60, Núm. 1, pp. 151-162

2014

  1. Analytical, experimental, and Monte Carlo system response matrix for pinhole SPECT reconstruction

    Medical Physics, Vol. 41, Núm. 3

  2. The performance of a hybrid analytical-Monte Carlo system response matrix in pinhole SPECT reconstruction

    Physics in Medicine and Biology, Vol. 59, Núm. 24, pp. 7573-7585

2012

  1. Effect of scatter coincidences, partial volume, positron range and non-colinearity on the quantification of FDOPA patlak analysis

    Iranian Journal of Nuclear Medicine, Vol. 20, Núm. 1, pp. 11-18

2010

  1. Geometrical and Monte Carlo projectors in 3D PET reconstruction

    Medical Physics, Vol. 37, Núm. 11, pp. 5691-5702

2009

  1. Comparison of NEMA NU 4-2008 vs NEMA NU 2-2001 for the performance evaluation of the microPET R4 system

    IEEE Nuclear Science Symposium Conference Record

2008

  1. Assessment of SPM in perfusion brain SPECT studies. A numerical simulation study using bootstrap resampling methods

    IEEE Transactions on Biomedical Engineering, Vol. 55, Núm. 7, pp. 1849-1853

2005

  1. Influencia de la dispersión de fotones en la cuantificación de cambios relativos en estudios longitudinales de PET cerebral con 18F-FDG

    Revista Espanola de Medicina Nuclear, Vol. 24, Núm. 6, pp. 404-409

2002

  1. Conferencia de Consenso sobre el ganglio centinela en el cáncer de mama. Valencia, 8 de Octubre de 2001. Organizada por la Sociedad Española de Cirugía Oncológica

    Clinical and Translational Oncology

1999

  1. Multicenter evaluation of the Elecsys® CA 125 II assay

    Anticancer Research

1998

  1. Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125

    Clinical Chemistry, Vol. 44, Núm. 12, pp. 2530-2536

1988

  1. Clinical utility of prostatic specific antigen and prostatic acid phosphatase serum levels in monitoring prostate cancer.

    The International journal of biological markers, Vol. 3, Núm. 1, pp. 23-28

1987

  1. Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: Are they helpful in staging prostatic cancer

    Journal of Urology, Vol. 137, Núm. 5, pp. 891-893

  2. CA 50 serum levels in patients with liver diseases.

    The International journal of biological markers, Vol. 2, Núm. 3, pp. 207-208

1986

  1. Evidence of a relationship between high serum CA 125 and liver failure pattern in cirrhotic patients without ascitis and jaundice.

    The International journal of biological markers, Vol. 1, Núm. 1, pp. 55-56

1983

  1. Influence of exercise on serum levels of myoglobin measured by radioimmunoassay

    European Journal of Nuclear Medicine, Vol. 8, Núm. 4, pp. 159-161